DiMeglio LA, Kanapka LG, DeSalvo DJ, et al. - In this randomized clinical trial, researchers sought to assess the impacts of continuous glucose monitoring (CGM) combined with the family behavioral intervention (CGM+FBI) and CGM alone (Standard-CGM) on glycemic outcomes and parental quality of life compared with blood glucose monitoring (BGM) in children ages 2 to < 8 years with type 1 diabetes. The sample consisted of 143 youth 2 to < 8 years of age with type 1 diabetes. Nearly 90% of candidates in the CGM groups used CGM ≥ 6 days/week at 6 months. In young children with type 1 diabetes, CGM used regularly over a 6-month period did not improve time in range but did significantly decrease time in hypoglycemia. Parental well-being was favorable to the FBI.